Covid19Au20-15NCT04834882
Burnout, Stress and Coping Strategies: Impact of the Covid-19 Epidemic
An observational study of Covid19 and Burnout, Professional, run by CHU de Reims at 1 site in France.
Trial summary
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel coronavirus detected in Wuhan, China on December 2019. This virus is responsible for the infectious respiratory disease called Covid-19. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Covid19, Burnout, Professional
- What is being tested?
- Data collection (
- How many people
- 649 participants
- Where
- 1 siteFrance
- Study dates
- 20 Jan 2021to 6 Apr 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: All healthcare workers participating will be included in the study
Who may be able to join
- Medical (physicians, interns) and paramedical (nursing managers, nurses, care assistants) staff in Reims University Hospital and EPSM Marne
- Person who have attained majority
- Person consenting to participate to the study
Who cannot join
- Healthcare workers outside of Reims University Hospital and EPSM Marne
- Person who is not a healthcare professional
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Burnout, Stress and Coping Strategies: Impact of the Covid-19 Epidemic on the Medical and Paramedical Staff in Reims University Hospital and EPSM Marne
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel coronavirus detected in Wuhan, China on December 2019. This virus is responsible for the infectious respiratory disease called Covid-19.
The psychological effects of this epidemic are found among the general population, but also healthcare workers. Some studies have shown that psychological disorders such as stress, anxiety, depressive symptoms, insomnia, denial, anger and fear, post-traumatic stress disorder are emerging among healthcare workers. However, there is currently insufficient data to evaluate the burnout during the COVID-19 pandemic.
The purpose of this study is to understand the impact of the covid-19 epidemic on stress and burnout on healthcare workers and their coping strategies.
Read the detailed description
Burnout syndrome, a state of professional exhaustion, is prevalent among the medical and paramedical staff. The covid-19 pandemic may generate more stress and increase the risk for burnout.
The aim of this study is to evaluate burnout (prevalence and intensity) and stress of among healthcare workers in COVID-19 units and non COVID-19 units. We also explore the supportive coping strategies need to reduce their stress and burnout.
- Conditions
- Covid19, Burnout, Professional
- Being tested
- Data collection (
- Medical subject headings
- COVID-19, Burnout, Professional
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Data collection (Other
online survey
| Study group | Role | What they receive |
|---|---|---|
| Healthcare workers | Medical and paramedical staff in Reims University Hospital and EPSM Marne working in COVID-19 units and non COVID-19 units Receives: Other: Data collection ( |
What is being measured
The primary outcome is the main question the study is designed to answer.
Assessment of burnout (prevalence and intensity)
Self-Administered Questionnaires : Maslash Burnout Inventory-Human Services Survey
Measured: Day 0
Assessment of stress
Self-Administered Questionnaires : Perceived Stress Scale
Measured: Day 0
Secondary outcomes (1)
Assessment of supportive coping strategies
Self-Administered Questionnaires : Ways of Coping Checklist (WCC-R)
Measured: Day 0
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Apr 2021
- Study start20 Jan 2021
- Primary completion6 Apr 2021
- Study completion6 Apr 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Covid19Studies of the same condition, open and under way.
- More trials run by CHU de ReimsThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 649 participants (actual)
Sponsor and investigators
- Lead sponsor
- CHU de Reims
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04834882
- Sponsor's protocol ID
- PO20152*
- Acronym
- Au20-15
- Status last verified
- May 2022
- First submitted
- 31 Mar 2021
- Last updated
- 23 May 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 23 May 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Burnout, Stress and Coping Strategies: Impact of the Covid-19 Epidemic on the Medical and Paramedical Staff in Reims University Hospital and EPSM Marne
- ClinicalTrials.gov ID
- NCT04834882
- Acronym / sponsor ID
- Au20-15 / PO20152*
- Conditions
- Covid19, Burnout, Professional
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 649 participants (actual)
- Lead sponsor
- CHU de ReimsUniversity, hospital or other
- Study start
- 20 Jan 2021 (actual)
- Primary completion
- 6 Apr 2021 (actual)
- Study completion
- 6 Apr 2022 (actual)
- First posted
- 8 Apr 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel coronavirus detected in Wuhan, China on December 2019. This virus is responsible for the infectious respiratory disease called Covid-19.
The psychological effects of this epidemic are found among the general population, but also healthcare workers. Some studies have shown that psychological disorders such as stress, anxiety, depressive symptoms, insomnia, denial, anger and fear, post-traumatic stress disorder are emerging among healthcare workers. However, there is currently insufficient data to evaluate the burnout during the COVID-19 pandemic.
The purpose of this study is to understand the impact of the covid-19 epidemic on stress and burnout on healthcare workers and their coping strategies.
Detailed description
Burnout syndrome, a state of professional exhaustion, is prevalent among the medical and paramedical staff. The covid-19 pandemic may generate more stress and increase the risk for burnout.
The aim of this study is to evaluate burnout (prevalence and intensity) and stress of among healthcare workers in COVID-19 units and non COVID-19 units. We also explore the supportive coping strategies need to reduce their stress and burnout.
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Healthcare workers | – | Other: Data collection (Medical and paramedical staff in Reims University Hospital and EPSM Marne working in COVID-19 units and non COVID-19 units |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- All healthcare workers participating will be included in the study
Key inclusion criteria (3 listed)
- Medical (physicians, interns) and paramedical (nursing managers, nurses, care assistants) staff in Reims University Hospital and EPSM Marne
- Person who have attained majority
- Person consenting to participate to the study
Key exclusion criteria (2 listed)
- Healthcare workers outside of Reims University Hospital and EPSM Marne
- Person who is not a healthcare professional
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Data collection (online survey | Other | Healthcare workers |
Primary outcome
Assessment of burnout (prevalence and intensity)
Time frame: Day 0
Self-Administered Questionnaires : Maslash Burnout Inventory-Human Services Survey
Assessment of stress
Time frame: Day 0
Self-Administered Questionnaires : Perceived Stress Scale
1 secondary outcome
Assessment of supportive coping strategies
Time frame: Day 0
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 May 2022.
- Individual participant dataSharing planned: Undecided
Related trials for Covid19
Not yet recruitingPhase 1
Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)
Post-Acute COVID-19 Syndrome
Active, not recruitingPhase 1
A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults
COVID-19
Active, not recruiting
Intervention to Address Disparate Mental Health Consequences of COVID-19 Pandemic on Latinx and African Newcomers
Mental Health Issue, Mental Health Disorder
Recruiting
Home-Based Exercise Tele-Rehabilitation After COVID-19
Post SARS-CoV2 (COVID-19)
Not yet recruitingPhase 1
A Safety, Reactogenicity and Immunogenicity Trial of RVX-sCPD9 Booster Intranasal COVID-19 Vaccine
COVID -19
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Covid19 and Burnout, Professional, run by CHU de Reims at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 23 May 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Assessment of burnout (prevalence and intensity) (time frame: Day 0). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 May 2022.